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ecent Developments in Heart Failure Imaging
homas H. Marwick, MD, PHD,* Subha V. Raman, MD,† Ignasi Carrio´, MD,‡
eroen J. Bax, MD, PHD§
leveland and Columbus, Ohio; Barcelona, Spain; and Leiden, the Netherlands
espite the central role of echocardiography in its primary assessment, heart failure is a condition inwhich
ccess to multiple cardiovascular imaging modalities is important. A number of important observations
elative to this topic have been made in the last year, including the assessment of left ventricular syn-
hrony, myocardial mechanics, heart failure with preserved ejection fraction, metabolic imaging, assess-
ent of myocardial viability, and fusion imaging. (J Am Coll Cardiol Img 2010;3:429–39) © 2010 by the
merican College of Cardiology Foundationc
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St. Jhere has been a recent explosion in cardio-
ascular imaging modalities, particularly those
ertaining to the evaluation of left ventricular
LV) function. Although this progress has
rovided a challenge for the imaging specialist,
t is almost overwhelming for the busy clinical
ardiologist or heart failure (HF) specialist to
eep up with the evolving role of the different
maging techniques to facilitate the care of HF
atients and to better understand the underly-
ng mechanisms of the disease. This review
ighlights recent observations using different
maging modalities (echocardiography, cardiac
agnetic resonance [CMR], cardiac computed
omography [CT], single-photon emission
omputed tomography [SPECT], and fusion
maging including positron emission tomog-
aphy–computed tomography [PET-CT], but
lso neuronal imaging with metaiodobenzyl-
uanidine [MIBG]) in the field of HF, includ-
ng both systolic HF and HF with normal
jection fraction (HFNEF). This review ad-
resses clinically relevant HF topics: LV me-
rom the *Cleveland Clinic, Cleveland, Ohio; †Ohio State Univers
au, Barcelona, Spain; and the §Leiden University Medical Center
rant support from GE Healthcare, Siemens, Philips Medical Syst
eceived grant support from Siemens. Dr. Bax has received research g
cientific, Edwards Lifesciences, GE Healthcare, Medtronic, andanuscript received December 15, 2009; revised manuscript received Fhanical synchrony, HFNEF, myocardial via-
ility, and identification of underlying HF
tiology.
V Synchrony
he clinical relevance of LV mechanical syn-
hrony to decision making about cardiac resyn-
hronization therapy (CRT) has become more
ontroversial over the last year. Before the
ublication of the PROSPECT (Predictors of
esponse to CRT) study results (1), there was
mbiguity between the reported accuracy of
chocardiographic measures in single-center
tudies (2) and the current guidelines, which
se QRS duration as the only marker for
yssynchrony (3). The PROSPECT study was
n observational study of CRT response (de-
ned by an improved clinical score and 15%
eduction in LV end-systolic volume at 6
onths) in nearly 500 patients with standard
RT indications (New York Heart Associa-
ion [NYHA] functional class III or IV HF,
edical Center, Columbus, Ohio; ‡Hospital Sant
iden, the Netherlands. Dr. Marwick has received
and Lantheus Medical Imaging. Dr. Raman has
ts from Biotronik, BMS Medical Imaging, Boston
ude Medical.ebruary 2, 2010, accepted February 22, 2010.
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430V ejection fraction [EF] 35%, QRS 130 ms,
nd appropriate medical therapy) in 53 centers in
urope, China, and the U.S., including 3 core
aboratories. Although the response rates were
lightly lower than previously reported (69% for the
linical score and 56% for the remodeling criterion),
he sensitivity of the echocardiographic markers was
80% (with several 10%), with specificities of
ome markers 90% (but others 35%). Not only
as the sensitivity for predicting response disap-
ointing, but so also was their reliability.
These findings have provoked extensive discus-
ion in the literature (4,5), which has included
onsideration of the role of mechanical synchrony.
he single-center data supported the initial clinical
bservation that responsiveness (the definition of
hich remains controversial) is related to baseline
ynchrony, and indeed the absence of synchrony is a
arker of either suboptimal or poor response. There is
o good evidence to disprove this hypothesis from the
ROSPECT study. Table 1 emphasizes how the
tudy shows the importance of a number of other
eterminants of nonresponsiveness, as well as the
ritical nature of a variety of study design issues that
hould guide subsequent studies, and the limitations
f the current techniques (2,4,6).
There is no denying that the success of single-site
xperience with several echocardiographic tech-
iques related to a level of standardization and
xpertise that may be difficult to replicate in daily
ractice in a general echocardiography laboratory.
hree groups of changes are needed before the
ssessment of mechanical synchrony becomes suit-
ble for another multicenter study to assess suitabil-
ty for patient selection for CRT—development of
more robust marker, a move from a categorical to
probabilistic approach to diagnosis of mechanical
ynchrony, and the use of combinations of measure-
ents. In a study of CRT response, Parsai et al. (7)
dentified 4 response criteria: reversal of the pre-
jection septal flash (present in 54% of patients and
lways associated with reverse remodeling), resolu-
ion of a short atrioventricular delay (in 13% of
Table 1. Contributors to the Failure of Echocardiographic Mark
Contributor
Other determinants of nonresponsiveness Scar tissue exte
Lead position (
Design limitations (7) Limited site exp
Incomplete dat
Poor agreemen
Measurements Lack of robustn
Use of categori
Failure to combineatients and associated with reverse remodeling in
4%) or a long atrioventricular delay (in 10% of
atients and associated with symptom improvement
n 88%), and resolution of marked interventricular
nteraction (present in 9% of patients, who showed
reduction of pulmonary artery pressure, but not a
eduction of LV volumes). In the 14% of patients
ho lacked these mechanisms, none had a response
o CRT.
The aftermath of the PROSPECT study has
een the proposal of using a variety of noninvasive
tudies to identify LV synchrony, including CMR
nd nuclear techniques. Automated edge detection
nd improvements in temporal resolution (to 40
rames per RR interval) will improve the feasibility
f CMR for this indication (8). A circumferential
niformity ratio derived from magnetic resonance
agging showed that control subjects had highly
ynchronous contraction (ratio 0.96  0.01).
eceiver-operator character curve analysis (area un-
er the curve 0.89) showed a cutoff value 0.75 to
dentify 56% of patients as showing mechanical
yssynchrony, with a positive and negative predic-
ive value of 87% and 100% for predicting improved
unctional class. The addition of scar imaging by
elayed enhancement further improved this predic-
ive value (9). Combining regional strain and scar
ata with CMR has shown promise in yielding a
ovel segmental dyssynchrony parameter in patients
ith ischemic cardiomyopathy (10).
Phase analysis of gated myocardial perfusion SPECT
llows the measurement of variations in phase as a
arker of LV dyssynchrony. In a study of 40 patients
ith severe HF (functional class III to IV, LVEF
35%, QRS duration 120 ms), tissue Doppler
ssessment of LV dyssynchrony correlated with his-
ogram bandwidth (r 0.69, p 0.01) and phase SD
r 0.65, p  0.01). Compared with CRT respond-
rs, nonresponders showed a smaller histogram band-
idth (94  23° vs. 68  21°, p  0.01) and a
arger-phase SD (26 6° vs. 18 5°, p 0.01). The
ptimal cutoffs for prediction of CRT response were
o Predict Outcome in the PROSPECT Study
ocalization, other aspects of cardiac structure and performance (6)
ise with echocardiographic markers
tween core laboratories
ather than probabilistic cutoffsers t
nt/l
4)
ert
a
t be
ess
cal rvariables
7
(
d
s
a
c
w
G
d
e
c
s
i
a
v
s
v
(
b
w
L
t
t
(
i
i
c
(
t
l
f
l
s
r
s
c
p
s
m
i
p
M
E
m
l
h
v
(
c
c
a
f
t
r
e
a
l
D
p
e
t
p
m
o
a
d
m
a
t
t
e
r
(
5
o
t
p
i
a
fi
h
g
e
I
d
r
v
m
H
c
d
i
t
o
A
r
a
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 4 , 2 0 1 0
A P R I L 2 0 1 0 : 4 2 9 – 3 9
Marwick et al.
Year in Heart Failure Imaging
4312.5° for histogram bandwidth and 19.6° for phase SD
sensitivity and specificity 80% to 85%) (11).
Cardiac CT may also help in assessment of LV
yssynchrony. In 38 subjects who underwent 64-
lice CT, the LV endocardial and epicardial bound-
ries were delineated from short-axis images, and
hanges in wall thickness during the cardiac cycle
ere used as measurement of cardiac dyssynchrony.
ood correlation was reported between the CT-
erived dyssynchrony index and 2- and 3-dimensional
chocardiographically derived indexes for LV dyssyn-
hrony (12).
The assessment of myocardial deformation
hould provide a more site-specific means of assess-
ng synchrony than tissue velocity imaging. Despite
previous publication showing inferiority of tissue
elocity–based strain, a more recent study in 120
ubjects showed considerable overlap of tissue
elocity–derived indexes among 40 control subjects
group 1), 20 patients with normal EF and left
undle branch block (LBBB) (group 2), 20 patients
ith EF35% and no LBBB, and 40 patients with
V dysfunction and LBBB. In contrast, the SD of
ime to peak strain in 12 segments distinguished
hese groups with much less overlap (p  0.01)
13). Newer echocardiography techniques not stud-
ed in the PROSPECT study include speckle track-
ng assessment of strain and 3-dimensional echo-
ardiography, both of which seem promising
Fig. 1) (14,15). A fundamental concern with all of
hese techniques is that their temporal resolution is
ess than the tissue velocity–based method; there-
ore, their ability to recognize dyssynchrony may be
imited to the extent that only the severe end of the
pectrum is recognized.
Although there remains a substantial controversy
egarding whether it is possible to define CRT re-
ponsiveness, there seems little doubt that both clini-
ians and patients are interested in being able to
redict symptomatic improvement with CRT. De-
pite the prognostic benefit of this treatment modality,
any patients with late-stage HF may be more
nterested in symptomatic response than improved
rognosis.
yocardial Mechanics and Diastolic Dysfunction
chocardiography is becoming the test of choice for
any studies of myocardial mechanics. Within the
ast year, normal ranges of 2-dimensional strain
ave been defined (16). Related techniques, such as
elocity vector imaging (VVI), have been validated
17); in a dog model, VVI measurement of gircumferential and longitudinal systolic strain
orrelated well with sonomicrometry (r  0.88
nd r  0.83, respectively, p  0.001). Although a
ully 3-dimensional technique such as CMR is able
o provide more exhaustive data about the geomet-
ic distribution of strain, the temporal resolution of
chocardiographic acquisition is more favorable,
nd further developments of speckle tracking are
ikely to further improve this temporal resolution.
etails of filtering and other aspects of signal
rocessing likely differ among techniques, perhaps
xplaining variations in strain measurement be-
ween different methods (Fig. 2).
The high spatial resolution of speckle tracking
ermits the measurement of endocardial, mid-
yocardial, and epicardial strain, permitting the rec-
gnition of different degrees of transmurality (10). In
comparison with contrast-enhanced CMR, epicar-
ial circumferential strain allowed distinction of trans-
ural from nontransmural infarction with a higher
ccuracy than strain measured from the total wall
hickness (area under the receiver-operator charac-
eristic curve 0.82 vs. 0.76, p  0.005). Similarly,
ndocardial circumferential strain was more accu-
ate than strain measured over the total thickness
0.84 vs. 0.77, p  0.001).
The ability of the heart to eject with an EF of
0%, in the context of myocardial fiber shortening
f 20%, is a miracle of the myocardial architec-
ure. Previous work (18) showed the untwisting
rocess occasioned by this fiber direction to be an
mportant contributor to early diastolic filling in an
nimal model. These findings have now been con-
rmed in a study of 18 patients who underwent
emodynamic manipulation during echocardio-
raphic assessment and simultaneous cardiac cath-
terization using micromanometer transducers (19).
mpaired relaxation was found to correspond to
elayed untwisting (r  0.35, p  0.01), and
eduction of the amount of untwisting before mitral
alve opening was associated with increased mini-
um diastolic pressure (r  0.30, p  0.03).
owever, untwisting was not found to be asso-
iated with LV stiffness, the latter being a late
iastolic property. The measurement of untwist-
ng velocity offers a potential understanding of
he early active component of LV filling, as
pposed to the later compliance effects (Fig. 3).
lthough the clinical utility of this measurement
emains undefined, its clinical application may
llow a more specific treatment strategy for sub-
roups with this condition.
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432The role of LV untwist has also been investigated
n relation to the cardiac filling response to exercise
20). In this study of 56 subjects undergoing exer-
ise echocardiography, longitudinal and radial
train as well as apical rotation were all reduced in
atients with HFNEF at rest and failed to increase
ith exercise. The HFNEF was associated with
educed and delayed untwisting with exercise, re-
Figure 1. Simultaneous Evaluation of Segments By 3D Echo and
(A) Simultaneous evaluation of all myocardial segments using real-t
ing of the endocardial border in all frames, regional volume–time c
Dyssynchrony is reﬂected by variations in time to minimum volume
of timing in all segments in the short-axis plane. Note that despite
ments, there are only minor variations in time to maximum inward
aortic valve closure (may be deﬁned from left ventricular outﬂow tr
valve, or marked from the end of the T-wave).uced LV suction, higher end-diastolic pressures, end reduced functional capacity, measured as VO2
ax. This report was important from several view-
oints. First, it confirms the link between systolic
nd diastolic function, as twist was related to
ntwist and untwist is the determinant of early
lling. Second, it reinforces the importance of
ssessment of LV mechanics and filling dynamics
uring exercise. Interestingly, it did not show an
Speckle
3-dimensional (3D) echocardiography. After semiautomated trac-
s are plotted for subvolumes corresponding to all LV segments.
every segment. (B) Use of radial strain for simultaneous evaluation
rogeneity in the maximum radial strain for the different LV seg-
lacement, implying the lack of signiﬁcant dyssynchrony. AVC 
Doppler, 2-dimensional (2D) echocardiographic visualization of the2D
ime
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433ntwist. This may reflect the relatively low temporal
esolution of current versions of speckle-tracking
chocardiography, and a technique such as tissue
elocity–based strain rate or high frame rate speckle
racking will be required.
The importance of HF with preserved systolic
unction is well described. The last year has seen
mportant confirmation of the adverse outcome
ssociated with this condition (21). In conjunc-
ion with the European Association of Echocar-
iography, the American Society of Echocardi-
graphy has produced a position statement
egarding the diagnosis of diastolic dysfunction
22). A cornerstone of this evaluation is the
ssessment of LV filling pressure using the ratio
f transmitral flow and tissue velocity (E/e=).
his parameter has been the source of contro-
ersy this year, with an important study from the
leveland Clinic showing limited correlation
ith pulmonary wedge measurement (23) in pa-
ients after treatment for acute HF. Patients with
he worst function and largest LV volumes and
hose undergoing cardiac resynchronization ther-
py showed the worst correlation between E/e=
nd wedge pressure. These conditions are dia-
etrically opposed to its application in patients
ith HFNEF, and this work should not be
Figure 2. Different Approaches to the Assessment of Speckle St
Velocity vector imaging is based on tracking the endocardium, whe
myocardium.onsidered to refute the previous validation of i/e=, but it does add to the situations in which
his measurement may be misleading (including
itral regurgitation and annular tethering by
alcification or prosthesis).
ssessment of Myocardial Fibrosis
he presence of myocardial fibrosis is an important
ontributor to the development of HF, and a
urprisingly labile process that is amenable to treat-
ent with aldosterone-receptor blockers. Fibrosis
ay be either generalized or localized, and several
mportant observations have been made in the last
ear. In a study of 349 patients (mean LVEF 24%)
tudied between 2003 and 2006, the transmurality
core, measured by late-enhancement CMR, was
igher in patients with than without events (24). In
survival analysis, scar involving 30% of the total
yocardium was an independent predictor of death
r cardiac transplantation. Likewise, in 65 patients,
ollowed up over 17 months with nonischemic
ardiomyopathy (42% of whom showed late en-
ancement), 44% of patients with late enhancement
ad an event, compared with 8% without late
nhancement (25). Even after adjustment for LV
olume and functional status, late enhancement was
ssociated with an 8-fold increment of the compos-
automated function imaging tracks speckles throughout therain
reaste end point of HF hospitalization, implantable
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434ardioverter-defibrillator (ICD) discharge, and car-
iac death. Both studies document the prognostic
mportance of localized fibrosis in determination of
ardiac outcome. Fibrosis as a substrate for diastolic
ysfunction across a broad spectrum of HF etiolo-
ies was demonstrated by Moreo et al. (26); such
tudies offer a noninvasive approach to studying
ovel therapeutics for diastolic HF.
Diffuse fibrosis is more difficult to identify using
ate enhancement because the recognition of scar
issue is made with reference to normal myocardium.
potential strategy to avoid this is to compare
carring to an external reference such as skeletal
uscle (27). Mapping of the T1 time after gadolinium
nfusion is an alternative approach to quantifying the
otal extent of fibrosis (28). This sequence involves
lectrocardiogram-triggered, inversion-recovery-
repared K-space sampling at increasing inversion
imes from 50 ms to 1 s, 15 min after a gadolinium
nfusion. Images are processed at the varying inversion
imes to generate a T1 map (Fig. 4). In post-
ransplant patients undergoing myocardial biopsy,
1 time showed an inverse correlation with colla-
Figure 3. Phases of LV Filling
Phases of LV ﬁlling emphasizing the role of the active phase, where
interstitium, causing untwisting and suction. This phase contrasts w
decrease in LV pressure, and the latest passive period, when the LV
sure; DcT  deceleration time; MVO  mitral valve opening; UR en content (r  0.7, p  0.03). The HF subjects tere shown to have a significantly shorter T1 time
han control subjects (383  17 ms vs. 543  32
s, p  0.01). Interestingly, fibrosis was observed
ven in areas without delayed enhancement, em-
hasizing the fibrosis of remote areas in patients
ith ischemic cardiomyopathy. Impaired relaxation
nd restrictive filling are associated with more
brosis.
The pattern of delayed enhancement after cardiac
ransplantation may identify transplant coronary
rtery disease (29). More extensive transplant cor-
nary artery disease was associated with more ex-
ensive delayed enhancement. Atypical forms (dif-
use, spotty, intramural, and inferoseptal) are also
ssociated with transplant coronary artery disease,
lthough LV function was significantly better than
n the patients with infarcts. These observations are
ikely to be relevant to clinical outcome. The ther-
peutic implications of these findings, other than
ossibly intensifying therapy for potential coronary
rtery disease, need to be defined.
Finally, late enhancement has been shown to
ffer particular diagnostic and prognostic value in
ecoil leads to release of elastic energy in the sarcomeres and
the intermediate phase, wherein relaxation contributes to the
elaxed and ﬁlling is based on compliance. AVC  aortic valve clo-
isting rate.in r
ith
is rhe assessment of amyloidosis (30), where it as-
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435umes a characteristic pattern, involving the entire
ubendocardial surface extending to the adjacent
yocardium. This is a rare finding in individuals
ho lack biopsy evidence of amyloidosis, with a
ensitivity of 88% and a specificity of 95%.
yocardial Metabolism
he current epidemic of “diabesity” is likely to
ontribute to a fresh increment in the HF epidemic.
n its pre-clinical stages, HF is associated not only
ith fibrosis but also with disturbances of myocar-
ial function. In a substudy of the Strong heart
tudy, 446 nondiabetic American Indian adoles-
ents underwent metabolic testing, and 111 were
ound to satisfy criteria for the metabolic syndrome
31). This entity was associated with greater LV
ass index, higher LV wall thickness, and LV and
eft atrial enlargement. Despite a normal EF, the
etabolic syndrome was associated with reduced
id-wall shortening. These findings point toward
he development of subclinical myocardial dysfunc-
ion in individuals with metabolic disturbances,
ven in adolescence. Interestingly, imaging may not
e required for screening for this disorder; in the
ESA (Multi-Ethnic Study of Atherosclerosis)
tudy (25), HF was identified in 79 of 6,814
articipants at baseline over a 4-year follow-up.
lbuminuria and inflammatory markers were asso-
iated with the development of HF, suggesting that
hese simple tests could be used in the first step in
he pre-clinical identification of LV dysfunction
sing imaging strategies. Identifying subclinical
yocardial infarction with CMR was shown this
ear by Kwong et al. (32) to predict HF and other
dverse cardiovascular outcomes in diabetic
atients.
The link between metabolic disease and myocar-
Figure 4. T1 Mapping for the Assessment of Diffuse Fibrosis
Acquisition of triggered images at increasing inversion times, 15 mi
the deﬁned region of interest to derive a curvilinear ﬁt (green line)ial function may in part relate to disturbances of Pyocardial triglyceride content. In a study of mag-
etic resonance spectroscopy in middle-aged men,
yocardial triglyceride content was an independent
redictor of impaired diastolic function (33). A
urther potential contributor to myocardial dysfunc-
ion is epicardial adipose tissue, which surrounds
he coronary arteries and therefore may have a
isproportionate influence on the supplied myocar-
ium. Although the association between adipose
issue and coronary artery disease has been ques-
ioned (34), other evidence suggests that this entity
ight be important to myocardial function.
schemic Heart Failure
he standard techniques and their accuracy for the
ssessment of myocardial viability are well known.
everal recent articles have confirmed the prognos-
ic implications of contrast-enhancement CMR for
dentification of myocardial scar in a variety of
ettings (24,35). However, most recent advances
ave focused more on the most efficient strategies
or gathering the information required for clinical
ecision making.
The high negative predictive value of cardiac CT
maging for the detection of coronary artery disease
ay be useful for the differentiation between ischemic
nd nonischemic cardiomyopathy, the distinction of
hich has important therapeutic implications. A com-
arison of 64-slice CT and coronary angiography in
3 consecutive patients with dilated cardiomyopathy
howed a patient accuracy of 95% (36). The assess-
ent of stress and rest myocardial perfusion with CT
ay be of use in the assessment of stenosis severity,
ith recent data reporting a sensitivity of 79% with a
pecificity of 80% for detection of stenoses 50%,
lbeit not in an HF population (37). There is also
rowing interest in fusion, or hybrid imaging between
ter gadolinium infusion. The segment marked in red represents
obtain a T1 time in microseconds.n afET and CT, which enables integrated imaging with
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436ET assessing myocardial perfusion and CT detect-
ng coronary artery stenoses (Fig. 5); the ultimate use
f hybrid imaging in HF patients will be to define
oronary anatomy and LV scar with CT and residual
iability with F18-fluorodeoxyglucose PET imaging
38). For now, it seems that there is good agreement
egarding infarct size between computed tomography
nd other techniques (39), including SPECT (Fig. 6)
nd delayed-enhancement CMR (40).
Valve disease, which is frequently encountered in
F, also may be addressed by CT. Good agreement
or the detection of mitral or aortic valve disease has
een reported with transesophageal echocardiogra-
hy and CT (41). The precise delineation of mitral
orrelation of Inferior Scar By CT and Spect
of inferior scar at CT imaging (A) and an inferior perfusion defect
). The CT image shows a low-density area in the subendocardium
or wall. The SPECT image shows a reduction in tracer uptake in
gment, although the spatial resolution of the technique is insufﬁ-
ntify the transmural location of the defect. CT  computed
Figure 5. Fusion (PET-CT) Imaging in a 66-Year-Old Woman Wit
Electrocardiographic Evidence of LVH With Strain
Quantitative stress perfusion with oxygen-15 PET shows diffuse per
abnormally low perfusion in the RCA and LCX regions (B). Overlaid
stenoses, conﬁrmed at invasive angiography. The PET color code: b
mality; gold-brown  normal. Images courtesy of Dr. Juhani Knuuti
anterior descending coronary artery; LCX  left circumﬂex coronary
tomography; RCA  right coronary artery.o
; SPECT  single-photon emission computed tomography.alve anatomy may be especially important in HF;
T has been used to document posterior leaflet
ngles and mitral valve tenting heights as well as
ore outward displacement of the papillary muscles
n moderate to severe mitral regurgitation (42).
ardiac Sympathetic Imaging
maging of the extent of cardiac sympathetic inner-
ation (especially using cardiac MIBG imaging)
ay be used to risk stratify patients with HF, and
ay contribute to more appropriate use of ICD
mplantation. The largest body of prognostic results
n HF patients is based on the heart-to-
ediastinum ratio (HMR) (Fig. 7) derived from
lanar MIBG imaging (43). In a recent 2-year
ollow-up of ischemic and nonischemic HF patients
NYHA functional class II to IV, most with LVEF
50%) (44), late HMR and LVEF were the only
ignificant predictors of major cardiac events. An
MR of 1.75 gave a sensitivity of 84% and a
pecificity of 60% for prediction of events (2-year
vent-free survival 62% for late HMR 1.75 vs.
5% for late HMR 1.75). This adverse prognosis
as confirmed in a recent meta-analysis of 1,755
atients in 18 studies (45). In patients with stable,
ild-to-moderate ischemic and nonischemic HF
nd LVEF 45%, deterioration of MIBG uptake
n serial imaging is an independent predictor of
ardiac mortality (46). Indeed, cardiac MIBG imaging
as been shown to be a prognostic factor independent
History of Stress-Associated Chest Pain, Risk Factors, and
n abnormalities, most severe in the LAD region (A), but also
ngiography shows LAD occlusion and 70% RCA and 30% LCX
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rku PET Center, Finland. CT  computed tomography; LAD  left
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437he results of the ADMIRE-HF (AdreView Myo-
ardial Imaging for Risk Evaluation in Heart Failure)
rial (48) will provide prospective validation of the
otential role of MIBG scintigraphy in predicting
ife-threatening arrhythmias (including ICD dis-
harge) or cardiac death over 2-year follow-up in
atients with NYHA functional class II and III HF
nd LVEF 35%.
Lethal cardiac events are related to alterations
f cardiac autonomic innervation (49), indepen-
ent of plasma B-type natriuretic peptide and
VEF. Likewise, in patients with a history of
entricular arrhythmia, MIBG uptake is a pow-
rful predictor of recurrence, independent of age,
ex, coronary risk factors, medication use, history
f structural heart disease, and LV function (50).
ven in low-risk patients with ventricular tachy-
ardia (no structural heart disease, severe LV
ysfunction, or past cardiac arrest), HMR 2.8 is
ssociated with a 5-fold increased risk of sudden
eath or ventricular arrhythmias, independent of
ild LV dysfunction (51). In patients with stable
hronic HF and LVEF 40%, the association of
IBG washout rate with sudden death is inde-
endent of signal-averaged electrocardiogram,
eart rate variability, and QT dispersion (52).
inally, inducibility of ventricular tachyarrhyth-
ias during electrophysiology testing in patients
ith previous myocardial infarction is associated
ith disturbances of cardiac sympathetic inner-
ation (53).
onclusions
espite the central role of echocardiography in its
rimary assessment, HF is a condition in which
ccess to multiple cardiovascular imaging modalities
s of value. A number of important developments
elative to this topic have been made in the last year.
issue Doppler is now a central part of the evalu-
tion of HFNEF, and contrast-enhanced CMR isreporting—a report from the American diology/Americanhe results (and indeed treatment implications) of
echniques for the assessment of diffuse fibrosis
hould be considered developmental. Although
ome of these new technologies remain in a devel-
pmental phase (including the assessment of LV
ynchrony), others, such as neuronal and fusion
maging, are rapidly moving toward regulatory ap-
roval and likely incorporation into standard
ractice.
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Figure 7. Derivation of the HMR in a Patient Undergoing MIBG
The mediastinal region of interest is located in the midline betwe
lungs and between the lung apex and lower boundary of upper
num. The upper row shows a patient with severe heart failure (f
class III, EF 15%), who had an HMR of 1.1 and eventually require
transplantation. The lower row shows a patient with heart failure
tional class II, EF 24%) with an HMR of 2.2 and whose case follow
benign course. Modiﬁed, with permission, from Agostini et al. (4
EF  ejection fraction; HMR  heart to mediastinum ratio;
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